siRNA治疗方法:从长椅实验室. 在临床上向诊所提供服务
Cristina Romero-López1, Alfredo Berzal-Herranz1
1Instituto de Parasitología y Biomedicina López-Neyra, CSIC, PTS Granada, Av del Conocimiento 17, 18016 Granada, Spain.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
RNA干扰 (RNAi) 是一种在1998年发现的基因沉默机制. 这个过程使用小RNA分子来调节基因表达,提供治疗潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 1998年由Fire和Mello发现的RNA干扰 (RNAi) 彻底改变了分子生物学.
- RNAi是真核生物中保存的生物过程,涉及调节基因表达的小RNA分子.
研究的目的:
- 探索RNA干扰的基本机制.
- 研究RNAi在基因调节和治疗干预中的潜在应用.
主要方法:
- 使用了诸如基因沉默测试和RNA分析等技术.
- 采用模型生物来研究RNAi in vivo的影响.
主要成果:
- 证明双链RNA可以专门"敲击"基因表达.
- 确定了小RNA分子作为RNAi路径的关键介质.
结论:
- RNAi代表了理解基因功能和开发新型基因沉默疗法的强大工具.
- 这一发现为遗传学和医学研究开辟了新的途径.
相关概念视频
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K